2. Academic Validation
  3. LYP inhibits T-cell activation when dissociated from CSK

LYP inhibits T-cell activation when dissociated from CSK

  • Nat Chem Biol. 2012 Mar 18;8(5):437-46. doi: 10.1038/nchembio.916.
Torkel Vang 1,  Wallace H Liu,  Laurence Delacroix,  Shuangding Wu,  Stefan Vasile,  Russell Dahl,  Li Yang,  Lucia Musumeci,  Dana Francis,  Johannes Landskron,  Kjetil Tasken,  Michel L Tremblay,  Benedicte A Lie,  Rebecca Page,  Tomas Mustelin,  Souad Rahmouni,  Robert C Rickert,  Lutz Tautz
Affiliations

Affiliation

  • 1 Infectious and Inflammatory Disease Center, Sanford-Burnham Medical Research Institute, La Jolla, California, USA.
PMID: 22426112 DOI: 10.1038/nchembio.916
Abstract

Lymphoid tyrosine Phosphatase (LYP) and C-terminal Src kinase (CSK) are negative regulators of signaling mediated through the T-cell antigen receptor (TCR) and are thought to act in a cooperative manner when forming a complex. Here we studied the spatiotemporal dynamics of the LYP-CSK complex in T cells. We demonstrate that dissociation of this complex is necessary for recruitment of LYP to the plasma membrane, where it downmodulates TCR signaling. Development of a potent and selective chemical probe of LYP confirmed that LYP inhibits T-cell activation when removed from CSK. Our findings may explain the reduced TCR-mediated signaling associated with a single-nucleotide polymorphism that confers increased risk for certain autoimmune diseases, including type 1 diabetes and rheumatoid arthritis, and results in expression of a mutant LYP that is unable to bind CSK. Our compound also represents a starting point for the development of a LYP-based treatment of autoimmunity.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z